Results 121 to 130 of about 30,982 (215)

Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine

open access: yesTurkish Journal of Hematology, 2022
Tekin Guney   +4 more
doaj   +1 more source

The Developmental and Functional Implications of Age‐Associated B Cells (ABCs) Across Tissue Microenvironments

open access: yesImmunological Reviews, Volume 341, Issue 1, August 2026.
ABSTRACT Age‐associated B cells (ABCs) are a dynamic B cell subset whose identity, development, and function are fundamentally shaped by the tissue microenvironments in which they reside. Primarily defined by expression of CD11c and T‐bet, ABCs arise across diverse contexts, including aging, infection, autoimmunity, and cancer, yet exhibit striking ...
Rebecca L. Francis, Jason S. Weinstein
wiley   +1 more source

Side effects to BNT162b2 can be severe.

open access: yesEuropean review for medical and pharmacological sciences, 2022
Finsterer, J., Scorza, F.A.
openaire   +2 more sources

Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults

open access: yes, 2023
Introduction: Vaccination is a critical tool for preventing coronavirus disease 2019 (COVID-19) and influenza illnesses. Coadministration of the COVID-19 vaccine, BNT162b2, with seasonal inactivated influenza vaccine (SIIV) can provide substantial ...
S Bull (16141301)   +39 more
core  

Erythema Multiforme after BNT162b2 Vaccination

open access: yesInternal Medicine, 2022
Katayama, Sho, Ota, Mitsuhito
openaire   +2 more sources

Acute interstitial nephritis after vaccination with BNT162b2 [PDF]

open access: yesJournal of Nephrology, 2022
Rieckmann, Sonja   +7 more
openaire   +2 more sources

Hybrid immunity of the SARS-CoV-2 vaccine after the third doses in health workers

open access: yesRevista Habanera de Ciencias Médicas
Introduction: Hybrid immunity is the immune response of people infected with COVID-19 who received the SARS-CoV-2 vaccine. This combination is more powerful than the immunity that is generated after vaccination or infection alone.
Raúl Montalvo   +5 more
doaj  

A Pilot Single-Blinded, Randomized, Controlled Trial Comparing BNT162b2 vs. JNJ-78436735 Vaccine as the Third Dose After Two Doses of BNT162b2 Vaccine in Solid Organ Transplant Recipients

open access: yes, 2023
Solid Organ Transplant (SOT) recipients are at significant higher risk for COVID-19 and due to immunosuppressive medication, the immunogenicity after vaccination is suboptimal.
Arosemena, Leopoldo   +22 more
core   +1 more source

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents

open access: yesNew England Journal of Medicine, 2022
Guy Witberg   +14 more
openaire   +4 more sources

Effectiveness of BNT162b2 against COVID-19 in adolescents

open access: yesThe Lancet Infectious Diseases, 2022
Powell, Annabel A   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy